Designing with the Patient in Mind: Amplifying the Patient Voice in Medicines Development and Approval

05/12/2022

Insights from the patient community are valuable in designing and developing medicines and treatments that positively impact the patients who need them most. By including patients in each cycle of medicines development, from early research and clinical studies to approval and use of medicines, stakeholders in healthcare can ensure that the patient voice is heard and incorporated to improve health outcomes. Join us for this panel discussion, featuring advocates with global experience, who will examine early research, clinical development and Health Technology Assessment/Regulatory from the perspectives of the advocate and patient communities.

Session Resources

Health Technology Assessment (HTA) 101

Speakers

Winselow Tucker
Winselow Tucker
Senior Vice President, Intercontinental, Bristol Myers Squibb

View Bio

Neil Bertelsen
Neil Bertelsen
HTAi Patient and Citizen Involvement Group

View Bio

Catherine Kopil
Catherine Kopil
SVP, Clinical Research, The Michael J. Fox Foundation for Parkinson's Research

View Bio

Kate Morgan
Kate Morgan
Head of Policy and Access, Myeloma Patients Europe

View Bio